|By PR Newswire||
|February 27, 2014 10:34 AM EST||
LONDON, Feb. 27, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
TechNavio's analysts forecast the Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the aging population. The Global Parkinson's Disease market has also been witnessing the transition toward using drugs that have new mechanisms of action. However, weak pipeline landscape could pose a challenge to the growth of this market.
TechNavio's report, the Global Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Parkinson's Disease market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva Pharmaceuticals Industries Ltd.
The other vendors mentioned in the report are AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc., BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International SRL.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
04. Market Research Methodology
Market Research Process
05. Scope of the Report
06. Market Landscape
06.1 Global Parkinson's Disease Market
Market Size and Forecast
06.2 Market Segmentationby Drug Class
06.3 Five Forces Analysis
07. Geographical Segmentation
08. Key Leading Countries
09. Rate of Incidence and Prevalence
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1 GlaxoSmithKline plc
17.2 Novartis AG
17.3 Orion Corp.
17.4 Teva Pharmaceuticals Industries Ltd.
18. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Market Overview of Global Parkinson's Disease Market
Exhibit 3: Global Parkinson's Disease Market 2012-2016 (US$ billion)
Exhibit 4: Global Parkinson's Disease Market Segmentation
Exhibit 5: Global Parkinson's Disease Market Segmentation 2012
Exhibit 6: Global Parkinson's Disease Market by Geographical Segmentation 2012
Exhibit 7: Business Segmentation of GlaxoSmithKline plc.
Exhibit 8: Business Segmentation of Novartis AG
Exhibit 9: Business Segmentation of Orion Corp.
Exhibit 10: Business Segmentation of Teva Pharmaceuticals Industries Ltd.
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
GlaxoSmithKline plc, Novartis AG, Orion Corp., Teva Pharmaceuticals Industries Ltd., AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc., BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International SRL.
Read the full report:
Global Parkinson's Disease Market 2012-2016